Biostime completes 100% acquisition of Swisse

Summary: In Feb. 2017, Biostime completed 100% acquisition of Australia healthcare brand Swisse, following its purchase of an 83% stake in Sept. 2015. In light of increased sales of Swisse and decreased profits from IMF products, Biostime expects tha...

Vitamins China E-News 201702

www.cnchemicals.com